Asante Bio
PrivateLast Round
Accelerator
Jun 4, 2025
Total Funding Raised
$1.56M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Asante Bio is a medical device company that develops regenerative orthobiologic implants using innovative biomaterials and biomanufacturing technologies for the orthopedics and sports medicine markets.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, 3D Printing, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Asante Bio Comparables
Compare Asante Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Miach Orthopaedics | 81% | |
| Nanochon | 80% | |
| Zimmer Biomet | 79% |
Asante Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 4, 2025 | ||||
| Grant | May 1, 2024 | ||||
| Grant | Nov 1, 2022 | ||||
| Grant | May 23, 2022 | ||||
| Grant | Mar 1, 2022 |
Asante Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NIH RADx | Grant |
| U.S. Department of War | Grant |
| The Florida High Tech Corridor | Accelerator |
| Foley & Lardner LLP | Accelerator |
| University of South Florida Research Foundation | Accelerator |
| USF Health Center for Advanced Medical Learning and Simulation (CAMLS) | Accelerator |
| Tampa Bay Wave | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Monthly visitors increased 62% MoM.
- May 11, 2026
Monthly visitors increased 207% MoM.
Asante Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Asante Bio's valuation, stock price, and market status.
Is Asante Bio a public or private company?
Asante Bio is a private company.
What is the current stock price of Asante Bio?
Asante Bio is a private company with no public stock price. No recent secondary market data is available.
How much is Asante Bio worth (valuation)?
Valuation information for Asante Bio is not publicly available.
Can I buy Asante Bio stock?
Asante Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Asante Bio's last funding round?
Asante Bio's most recent funding round was Accelerator on June 4, 2025.
Who are the main investors in Asante Bio?
Key investors in Asante Bio include NIH RADx, U.S. Department of War, Tampa Bay Wave, National Science Foundation.
Will Asante Bio IPO soon?
No public IPO plans have been announced for Asante Bio.
How can I track Asante Bio secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Asante Bio's secondary market activity and sign up for updates.